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Abstract 
Rationale: Despite the preferred application of arterial conduits, the greater saphenous vein (SV) remains 
indispensable for coronary bypass grafting (CABG), especially in multi-vessel coronary artery disease (CAD). 
The objective of the present work was to address the role of mechanical forces in the activation of maladaptive 
vein bypass remodeling, a process determining progressive occlusion and recurrence of ischemic heart disease. 
Methods: We employed a custom bioreactor to mimic the coronary shear and wall mechanics in human SV 
vascular conduits and reproduce experimentally the biomechanical conditions of coronary grafting and 
analyzed vein remodeling process by histology, histochemistry and immunofluorescence. We also subjected 
vein-derived cells to cyclic uniaxial mechanical stimulation in culture, followed by phenotypic and molecular 
characterization using RNA and proteomic methods. We finally validated our results in vitro and using a model 
of SV carotid interposition in pigs. 
Results: Exposure to pulsatile flow determined a remodeling process of the vascular wall involving reduction 
in media thickness. Smooth muscle cells (SMCs) underwent conversion from contractile to synthetic 
phenotype. A time-dependent increase in proliferating cells expressing mesenchymal (CD44) and early SMC 
(SM22α) markers, apparently recruited from the SV adventitia, was observed especially in CABG-stimulated 
vessels. Mechanically stimulated SMCs underwent transition from contractile to synthetic phenotype. 
MALDI-TOF-based secretome analysis revealed a consistent release of Thrombospondin-1 (TSP-1), a 
matricellular protein involved in TGF-β-dependent signaling. TSP-1 had a direct chemotactic effect on SV 
adventitia resident progenitors (SVPs); this effects was inhibited by blocking TSP-1 receptor CD47. The 
involvement of TSP-1 in adventitial progenitor cells differentiation and graft intima hyperplasia was finally 
contextualized in the TGF-β-dependent pathway, and validated in a saphenous vein into carotid interposition 
pig model. 
Conclusions: Our results provide the evidence of a matricellular mechanism involved in the human vein 
arterialization process controlled by alterations in tissue mechanics, and open the way to novel potential 
strategies to block VGD progression based on targeting cell mechanosensing-related effectors. 
Key words: coronary artery bypass grafting, vein graft disease, mechanotransduction, Thrombospondin-1, 
arterialization  
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Introduction 
Coronary artery bypass grafting is used in 
cardiac surgery for more than 50 years to combat the 
consequences of coronary artery disease [1-3], a 
pathology with a wide incidence in Western world (> 
1000 cases/ 106 adult people) and rapidly increasing 
in emerging countries – e.g. China [4]. The most 
represented coronary-compatible vessels used in 
CABG are the internal mammary artery (IMA), the 
radial artery (RA) and the SV. The patency of arterial 
grafts is relatively well preserved, while the SV 
conduits are subject to intima hyperplasia 
determining progressive graft occlusion. In a high 
percentage of cases, this requires re-hospitalization 
with graft stenting and, ultimately, re-intervention [1, 
2]. More in details, early vein graft failure due to acute 
thrombosis occurs in as many as 18% of cases. 
Intermediate graft failure (up to 2 years after surgery), 
and late graft failure (> 2 years after surgery), occurs 
in 20% to 50% of cases at 5 years. Finally, by 10 years 
after surgery, 40% of grafts result completely blocked 
and a further 30% have a compromised flow. Even if 
early remodelling of the vein is predictive for later 
graft patency, the aetiology of long-term failure is still 
poorly understood [5]. Initially, both the surgical 
procedure and exposure to high flow and pressure 
compromise the endothelial layer, which induce 
SMCs proliferation [6, 7], changes in matrix 
composition, and thickening/stiffening of the vessel 
wall. This limits the vein’s adaptability to the arterial 
circulation and ultimately leads to clinically apparent 
stenosis [8]. Animal models revealed that occlusion of 
autologous SV grafts is a consequence of neointima 
formation, driven by proliferation and migration of 
SMCs and possibly of adventitial progenitors into the 
intima [9], inducing extracellular matrix (ECM) 
deposition, and formation of a thick neointima [10]. 
The role of mechanical forces in the progression 
of graft failure has been recognized, although the 
nature of cell-based mechanosensing in the vascular 
tissue remains unclear due the difficulty of 
decoupling distinct components in vivo [11, 12]. In 
fact, the existing studies have not yielded conclusive 
results on the effect of mechanical stimulation on SMC 
growth and phenotype, with results depending on 
direction, frequency, duration and modality of the 
stimulus, but also on the origin and initial phenotype 
of the SMCs. For example, cyclic strain of human 
SV-derived SMCs resulted in increased DNA 
synthesis and cell number with a decrease in smooth 
muscle α-actin (αSMA) [13-15], while cells of arterial 
origin showed opposite effects [16, 17]. Ex vivo vessel 
culture systems (EVCSs) and bioreactors to stimulate 
cells mechanically offer the unique possibility to 
investigate the effects of isolated or combined 
mechanical stimuli under well-controlled and repro-
ducible biomechanical and/or metabolic conditions in 
human large vessels. In this framework, the aim of the 
present investigation was to characterize the effect of 
coronary mechanical conditions on molecular 
programming of vein graft disease using an 
integrated tissue/cell biomechanical approach. 
Methods 
Extended Methods are provided in the Methods 
section in the online only Data Supplement. 
Ethics 
The experimental investigation on human- 
derived tissues and cells was approved by the local 
ethical Committee at Centro Cardiologico Monzino, 
IRCCS. Patients were required to sign an informed 
consent. The use of human material was done in 
compliance with the Declaration of Helsinki. The 
main patient characteristics are shown in Table S1. 
Arteriovenous bypass procedures in pigs were 
performed in female Landrace or Large White/ 
Landrace crossbred pigs weighing 20 to 30 kg. All 
animals received humane care in accordance with the 
Home Office Animals (Scientific Procedures) Act of 
1986 and the Guide for the Care and Use of 
Laboratory Animals published by the US National 
Institutes of Health (NIH Publication No. 85- 23, 
revised 1996). For surgery, anaesthesia was induced 
with a single dose of intramuscular ketamine into the 
neck (0.1 mg/Kg ketamine: Ketaset Injection Fort 
Dodge Animal Health Ltd, Southampton, UK). After 
endotracheal intubation, anaesthesia was maintained 
using 2-3% halothane and oxygen, the animals 
ventilating spontaneously throughout. Animals were 
euthanized with 100 mg/Kg intracardiac injection of 
pentobarbitone in a single dose (Euthatal; 200 mg/mL 
pentobarbital sodium, J.M. Loveridge Plc, 
Southampton, UK). 
Tissue/cells mechanical stimulations 
Mechanical stimulations of SV grafts were 
performed using a custom-made bioreactor [18] 
tailored to reproduce the coronary mechanics. Cell 
straining was performed with Flex-Cell system. 
Mechanical stimulation times ranged from 7 to 14 
days for SV grafts and from 1 to 3 days for cells. 
Tissue/cells analyses 
After mechanical stimulation, tissues, cells and 
culture supernatants were prepared and appropri-
ately processed for histological, immunohistochemi-
cal, immunofluorescence, protein/secretome and 
RNA analyses, as already published [19], and 
described in the extended online methods. 
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In vitro cell culture 
Isolation of cells for in vitro experiments was 
performed as previously described [20, 21], using 
immunomagnetic and/or plastic adherence selection. 
Migration experiments were performed using 
Transwell-based assays followed by quantification of 
Crystal-Violet cell staining. 
Molecular analyses 
Tissue/cells RNA and protein content was 
analysed by Q-RT-PCR and Western blotting 
performed with protocols already published [19], 
while the secretome analysis was conducted using a 
MALDI-TOF methods as already described [22]. 
Data representation and statistical analyses 
In all graphs throughout the manuscript, data 
were plotted as mean ± standard error using 
GraphPad Prism 7. A P value < 0.05 was considered 
significant. The type of statistical test employed for 
data comparison is specified in figure legends. As a 
general rule, comparisons between two independent 
samples were performed by unpaired/paired t-test 
(two-tails), while for comparisons between 3 or more 
groups we adopted one-way ANOVA with post-hoc 
comparisons tests. The specification of the number of 
independent samples included in the analyses and the 
type of statistical tests used to compare data are 
specified in the legends to figures. Further details 
about data processing are provided in the online 
methods section. 
Results 
CABG-like hemodynamics induces consistent 
remodeling of human SV wall associated to 
SMCs phenotypic switching 
Our previous contributions showed that 
application of an 80-120 mmHg pulsatile pressure 
regimen determined a change in the SV structure at 7 
days, consisting of a significant thinning of the vessel 
wall, and elevation in cell death by apoptosis and 
enhanced proliferation [18, 19]. These changes were 
less evident in SVs exposed to venous flow (VP), 
characterized by a constant low pressure (5 mmHg). 
Confirming these findings, morphometric analyses of 
SVs treated with coronary flow showed a significant 
thinning of the medial layer (Figure 1A-B). In order to 
demonstrate the specific effects of mechanical forces 
on intima thickening, we compared results obtained 
in the presence of venous or coronary flow/pressure 
patterns with a conventional vein ‘rings’ culturing 
model[23]. Figure S1 and S2 show results of this 
experiment, which demonstrate that in the presence of 
coronary flow-pressure pattern intima thickening 
does not occur, at least at the considered time points. 
Since ex vivo cultured SVs exhibited a similarly 
elevated cellular apoptosis (Figure 2A-B), we investi-
gated whether application of a coronary-like flow 
pattern affected the phenotype of the surviving cells. 
To this aim, we performed IF staining with antibodies 
recognizing SMCs contractile markers αSMA (Figure 
3A)/Calponin (Figure 3B), and the synthetic SMCs 
marker Vimentin (Figure 3C). Cells quantification 
(Figure 3D) demonstrated a clear reduction in the 
percentage of αSMA+ and Calp+ cells in SV conduits 
stimulated with coronary flow/ pressure pattern, and 
a consistent increase in cells with synthetic character-
istics, suggesting a SMCs phenotypic transition.  
Coronary mechanics induces recruitment and 
proliferation of CD44+ cells in SV medial layer 
Recruitment of cells from the vascular adventitia 
has been identified as a key early event in VGD 
setting in animal vein arterialization models [24]. 
Furthermore, microscopic observations performed in 
explanted CABGs or SV grafts exposed ex vivo to 
trans-wall hypoxia gradients showed an enhanced 
growth of adventitia vessels [25]. Since CD44 marker 
expression has been associated to myofibroblast 
programming of stromal cells in fibrotic diseases [26, 
27], we investigated the expression of this marker 
after culturing SV grafts. In order to assess if cells 
expressing CD44 also expressed SMCs markers, we 
performed co-staining with anti-αSMA and -SM22α 
specific antibodies in control and ex vivo cultured SVs. 
As shown in Figure 4A-B very few CD44+ cells were 
present in the media of the vessels before the 
beginning of the culture. However, these cells 
increased time-dependently, in particular in CABG 
samples, where they exhibited a clear co-staining with 
SM22a. Quantification of cells confirmed that CD44+ 
and SM22α+ cell percentages increased under either 
VP or CABG stimulation at day 7, and continued to 
rise in CABG-stimulated vessels at day 14 (Figure 4C). 
The presence of CD44+/SM22α+ cells in CABG-treated 
SVs exhibited, finally, a substantial and constant 
increase (Figure 4C). Since the majority of CD44+ and 
SM22α+ cells at the beginning of the culture were 
confined in the adventitia in close association with the 
vasa vasorum (Figure S3), this suggests that coronary 
flow/pressure pattern activates adventitial cells 
expressing myofibroblasts/immature SMCs markers. 
In keeping with this conclusion, increase in 
CD44+/SM22α+ cells in CABG-stimulated grafts was 
associated to an elevated proliferation level (Figure 
5A-C), which was more pronounced initially in the 
adventitia (in particular in the vasa vasorum region), 
and later in the media, as detected by expression of 
PCNA marker. 
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Figure 1. (A) Low and high magnifications (zones enclosed in the yellow areas) of transversal sections of native SVs (T0) and SVs exposed to venous perfusion (VP) or coronary 
flow (CABG) for 7 and 14 days, stained with Masson’s trichrome. While in VP samples, the circumferentially arranged SMCs bundles (characterized by the red staining, yellow 
arrows) are present throughout the culturing period, in SVs exposed to CABG mechanics, part of these bundles disappeared (areas stained in blue, asterisks) leaving zones rich 
in collagen and deprived of cells. This suggests that circumferential SMCs bundles are a specific target of coronary flow mechanics. (B) Quantification of media thickness, 
confirmed a major effect of the CABG stimulation on SV wall remodeling. * indicate P < 0.05 by one-way ANOVA with Newman-Keuls post-hoc. Bar graphs represent mean and 
SE. Me = Media; Adv = Adventitia: In = Intima. 
 
Thrombospondin-1 is a mechanically regulated 
factor in the SV wall associated to SMCs 
switching from contractile to synthetic 
phenotype 
Mechanical forces exerted by the counter-pulsed 
coronary flow on vein wall expose vein-resident cells 
to a high level of strain, whose distribution is modi-
fied compared to the natural venous perfusion [12]. 
We then modelled in silico the level of cell 
deformation associated to the circumferential strain of 
the two major SV layers occurring in the presence of 
coronary flow mechanics. We were interested in this 
strain component considering the orientation of the 
circumferentially arranged SMCs bundles, which 
appeared the most affected structures in the media of 
CABG-stimulated SV conduits (Figures 1 and 3). As 
shown in Figure 6A, the model predicted a more 
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pronounced strain in the stiffer media (~ 26% 
elongation), and a lower strain value (~ 18% elonga-
tion) in the softer adventitia. Based on this evaluation, 
we decided to investigate the effects of uniaxial cell 
deformation on SMCs isolated from human SVs 
(Figure S4) using an in vitro cyclic cell strain setting. 
Figures S5 and 6B show the results of 24 and 72 h 
SMCs mechanical stimulation, which determined a 
significant reorientation of the cells. Under these 
conditions, these cells downregulated the contractile 
phenotype marker αSMA, and upregulated the levels 
of Vimentin (Figure 6B). They also exhibited a sub-
stantial rearrangement of the contractile cytoskeleton 
organization, which acquired an arrangement consis-
tent with the synthetic phenotype [21] (Figure S6). 
 
 
Figure 2. (A) Low and high magnifications (zones enclosed in the yellow areas) of transversal sections of native SVs (T0) and SVs exposed to venous perfusion (VP) or coronary 
flow (CABG) for 7 and 14 days stained with TUNEL assay for detection of apoptotic cells. Yellow arrows indicate TUNEL- cells while red arrows indicate TUNEL+ apoptotic cells. 
(B) Apoptosis quantification in the SV media at the two time points. * indicate P < 0.05 by one-way ANOVA with Newman-Keuls post-hoc. Bar graphs represent mean and SE. 
Me = Media. 
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Figure 3. (A-C) Confocal microscopy images of transversal sections of native SVs (T0) and SVs exposed to venous perfusion (VP) or coronary flow (CABG) for 7 and 14 days 
stained with antibodies recognizing contractile (αSMA, Calponin) and secretory (Vimentin) SMCs markers. Red arrows indicate cells expressing the indicated markers, while the 
cells indicated by white arrows are marker- cells. (D) Quantification of the marker+ cells expressed as a percentage of the total nuclei count present in the SV medial layer. Data 
are presented per treatment groups with blue bars indicating VP and red bars indicating CABG. * indicate P < 0.05 by one-way ANOVA with Newman-Keuls post-hoc 
comparison. Bar graphs represent mean and SE. 
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Figure 4. (A-B) Low and high magnifications of confocal images of SV tissue sections stained with CD44 with αSMA, (A) or SM22α (B) antibodies. While expression of αSMA 
was independent of that of CD44 (white arrows) a staining overlapping of CD44+ and SM22α+ (orange arrows) was observed especially in CABG samples at day 14 of stimulation. 
(C) Quantification of single marker+ cells or SM22α+/CD44+ cells in the medial layer of SV conduits exposed to venous perfusion or coronary flow revealed a sharp increase in 
double positive cells in the CABG conditions. * indicate P < 0.05 by one-way ANOVA with Newman-Keuls comparison tests; # indicate P < 0.05 by unpaired Student’s tests at 
the corresponding time points between the two treatments. Bar graphs represent mean and SE. 
 
In order to find a relationship between the 
phenotypic switch occurring in SMCs and the 
observed activation and presence of CD44+ cells, we 
performed a secretome analysis of proteins released in 
the culture medium by mechanically strained SMCs 
using a mass spectrometry-based approach. This 
indicated the matricellular protein Thrombospondin- 
1 (TSP-1) [28] as a factor released at high levels both at 
24 and 72 h of mechanical stimulation (Table S2). 
Mass-spec data were validated in independent 
biological replicates using IF and ELISA tests, which 
confirmed TSP-1 release from SMCs (Figure 6C). 
Interestingly, Western analysis of the protein extracts 
revealed a decrease of the intracellular content of 
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TSP-1 in mechanically stimulated SMCs (Figure 6C). 
Altogether these data indicate that mechanical strain 
induces release of TSP-1 from intracellular stores and 
a concomitant upregulation at transcriptional level, 
thus identifying TSP-1 as mechano-responsive gene. 
Finally, we performed immunohistochemistry and 
Western blotting analyses on tissue sections and 
protein extracts of samples treated with VP or CABG 
flow. This clearly showed a specific elevation of TSP-1 
in the intima and media compartments of 
CABG-stimulated vs. VP and control SVs (Figure 
6D-E). Immunofluorescence staining with anti-TSP-1 
and -SM22α antibodies indicated the presence of 
TSP-1+ cells with or without co-expression of the early 
SMCs marker in CABG-treated samples (Figure S8). 
 
 
Figure 5. (A-B) Immunofluorescence staining of CABG-treated SV conduits sections with PCNA marker in conjunction with CD44 (A) or SM22α (B). PCNA+ cells 
co-expressing (yellow arrows) or not co-expressing (rose arrows) the mesenchymal and the SMC markers were localized in the adventitia (Adv) at 7 days also in association with 
the vasa vasorum (VV) Dotted lines indicate the position of the external elastic lamina. (C) Quantification of CD44+/PCNA+ and SM22α+/PCNA+ cells in the medial layer. * indicate 
P < 0.05 by one-way ANOVA with Dunnett’s post hoc comparison test. Bar graphs represent mean and SE of observations. 
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Figure 6. (A) On the left side of the panel, a schematic of the structural components, the stiffness characteristics (expressed as Young’s modulus, E [kPa]) and the circumferential 
wall strain (εW) employed to compute cell stretching experienced by cells in the adventitial and in the medial layer when coronary blood pressure is applied. On the right side of 
the panel it is represented the predicted cell deformation maps in the medial (εW_Mcell) and adventitial (εW_AdvCell) layers, as a result of the circumferential wall strain. (B) Results 
of 10% cyclic stretching on orientation of SV-SMCs (see scheme showing the procedure adopted to calculate cellular orientation above the bar graph on the left); modulation of 
αSMA and Vimentin by Western blot analysis (right). (C) Western blotting and IF (left side and right side, respectively) of TSP-1 into mechanically stimulated cells; ELISA tests of 
TSP-1 release in the medium. TSP-1 gene expression analysis by Q-RT-PCR (central part of the panel). (D) TSP-1 immunohistochemistry in VP and CABG-stimulated SV samples. 
Statistical analysis indicated a significant difference in signal intensity at day 14 in CABG (red bars) vs. VP (blue bars) and T0 (white bars) samples. (E) Western blotting analysis of 
whole protein extracts from SV samples. As shown in the quantification graph, CABG-treated samples at day 14 (red bars) underwent a dramatic upregulation of TSP-1 compared 
with VP samples (blue bars) and earlier CABG time points, or controls. * indicate P < 0.05 by, (B, C) paired t-test, (D) one-way ANOVA with Newman-Keuls multiple comparison 
post-hoc test and unpaired t-test (E). Bar graphs represent mean and SE of observations. 
Theranostics 2020, Vol. 10, Issue 6 
 
 
http://www.thno.org 
2606 
 
Figure 7. (A) SVPs transwell migration assay; micrographs show the cells that migrated through the membrane pores stained with Crystal Violet (purple color). Bar graph 
indicates quantification of the Crystal Violet optical density (see methods). * indicate P < 0.05 by one-way ANOVA (repeated measures) with Newman-Keuls multiple comparison 
post hoc test. (B) FACS analysis of the main TSP-1 receptors in human SVPs (n = 4). (C-D) Inhibition of SVPs migration against recombinant TSP-1 (C) and strained SMCs 
conditioned medium (D) by CD47 blocking antibody. * in both panels indicate P < 0.05 by paired student’s t-test. (E) Effect of TSP-1/TGF-β treatment on SVPs phenotype. 
Q-RT-PCR analysis of TAGLN (SM22α), TGFβR, Col1A genes expression (upper). Data are represented as fold change (FC = 2-ΔΔCT) vs. untreated cells cultured for the same 
amount of time (dotted line). * indicate P < 0.05 by paired t-test performed on ΔCT values. Western blotting analysis of SM22α protein expression (lower). * indicates P < 0.05 
by paired t-test. (F) Effect of TSP-1/TGF-β treatment on SVPs proliferation (PCNA immunofluorescence, green). * indicate P < 0.05 by paired t-test. Bar graphs represent mean 
and SE of observations. 
 
TSP-1 induces migration of SV adventitial 
progenitor cells 
The human SV adventitia contains progenitor 
cells with pericyte characteristics, the so-called 
saphenous vein progenitors (SVPs) [20]. These cells 
are characterized by CD44 as well as other fibroblast/ 
stromal cells markers (Figure S9) [26], and may 
represent a potential source of cells participating to 
SV graft pathologic evolution by differentiating into 
myofibroblasts and SMCs [12]. In order to correlate 
the mechanical-dependent TSP-1 regulation in the SV 
wall and activation/recruitment of CD44+ cells, we 
performed migration assays in Transwells (Figure 
7A). Results showed that TSP-1 elevated the 
migration of the cells compared to serum only. As 
established in literature, TSP-1 exerts its cellular 
functions through specific receptors [28]. We therefore 
investigated the expression of TSP-1 receptors in SVPs 
using specific antibodies for CD36 and CD47, and this 
highlighted a high CD47 expression level (Figure 7B). 
To substantiate the role of TSP-1 on SVP migration, 
we treated cells with a blocking CD47 antibody in 
migration assays against the protein (Figure 7C) or the 
stretched SMCs conditioned medium (Figure 7D); in 
both cases, treatment with the antibody inhibited 
SVPs migration.  
Integration of mechanosensing- and 
humoral-driven pathways in pleiotropic SVPs 
responses in saphenous vein graft failure 
Taken together, the previous data suggested that 
CD44+/SM22α+ cells growing in SV conduits exposed 
to coronary mechanics are actively recruited from the 
adventitia where they initially reside; conversion from 
contractile to synthetic SMCs due to circumferential 
strain component attracts these cells in the medial 
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layer through secretion of TSP-1 and CD47-mediated 
chemotaxis. To get further insights in this process, we 
reasoned that transitioning from the adventitia to the 
media could expose cells to a combination of stimuli 
resulting from TSP-1 and classical vascular pro- 
remodeling factors, such as TGF-β [29]. On the other 
hand, we already showed that arterial-mimicking 
pressure elevates the expression of TGF-β in the SV, 
and literature reported a crucial function of TSP-1 for 
TGF-β pathologic activation of cells with mesen-
chymal and smooth muscle cells phenotypes [30, 31]. 
In order to substantiate this hypothesis, we stimulated 
SVPs with TGF-β (10 ng/mL) and TSP-1 (50 ng/mL), 
alone or in combination, followed by analysis of 
SM22α, Collagen1, TGF-βR, and cell proliferation. 
Results showed an increase in the expression level of 
the SMC/myofibroblast differentiation markers 
(Figure 7E-S10) and proliferation (Figure 7F-S11) at 
both times in cells treated with the factors combina-
tions. For a final confirmation of TSP-1 expression in 
failing of arterialized veins, we performed immuno-
staining with TSP-1 antibodies in sections of SV grafts 
transplanted into carotids in pigs [32]. As shown in 
Figure 8A-C, SV grafts underwent a significant 
thickening of the intima layer, which peaked at 90 
days post-transplantation. Concurrently, an increased 
number of cells expressing TSP-1(Figure 8B-C) and of 
SM22α+/CD44+ cells (Figure 8D) was observed in the 
wall of the implanted SVs. 
Discussion 
We and others have hypothesized an important 
role of hemodynamic forces in molecular 
programming of the SV graft disease [12]. On the 
other hand, the lack of platforms mimicking the 
peculiar flow/pressure pattern existing in the 
coronary circulation has prevented the identification 
of molecular pathways connected to alterations of SV 
mechanics directly in human samples. In the present 
investigation we filled this gap using a platform 
customized to maintain vessel viability and 
reproducing the hemodynamic conditions of the 
coronary circulation [18]. We found a major vessel 
remodeling effect consisting in, i) a substantial 
rearrangement of the intima and the media layers 
structure, ii) a major change in cell composition 
resulting from an early induction of apoptotic death 
in a significant portion of the SMCs, accompanied by 
a transition from a contractile to a synthetic 
phenotype of the surviving SMCs associated with 
TSP-1 release in the media, and iii) proliferation of a 
vessel-resident cell subset arising from the SV 
adventitia, characterized by expression of CD44 and 
SM22α, leading to a fibrotic-like response associated 
to TSP-1 release. 
Coronary mechanics induce SMCs phenotypic 
transition toward a synthetic phenotype and 
growth of a myofibroblast-like cell population 
in the SV media 
The first questions that we aimed to resolve was 
to define the structural rearrangement of the vessel 
wall subjected to CABG conditions and the cellular 
dynamics occurring in consequence of the coronary 
stimulation vs. the venous flow/pressure pattern. 
As shown in Figures 1, S1 and S2, under CABG 
conditions, the SV wall underwent a consistent thin-
ning with reduction of the overall media thickness. 
Interestingly, the coronary-like stimulation was not 
associated to intima growth, while VP-stimulated 
vessels (analogous to the conventionally accepted SV 
culture method) exhibited significant intima thicken-
ing at day 14. This result, although contra-intuitive, is 
in line with observations performed in SV CABGs 
explanted post mortem showing narrowing of the vein 
wall and absence of intima hyperplasia at early times 
after implantation [33]. It further supports the 
hypothesis, already made in two other previous 
publications from our groups [18, 25], that the SVs 
contain a certain degree of damage before the culture 
that depends on surgical manipulation (e.g. 
interruption of collateral vessels, partial removal of 
the adventitia). In support of this hypothesis is, 
finally, the finding that TUNEL staining showed a 
similar level of apoptotic cells, especially at 7 days of 
culture, irrespective of the flow pattern (Figure 2). 
IF data indicated that coronary mechanics 
induced synthetic SMCs phenotype, with a decrease 
in αSMA and Calponin and a parallel increase in 
Vimentin in the media layer (Figure 3). This is 
consistent with observations performed in animal 
models, in which medial SMCs lose contractile 
markers in favor of a synthetic phenotype [34, 35]. It is 
interesting to note that while disappearance of cells 
with contractile markers peaked at day 7, a consistent 
increase in Vimentin+ cells occurred at day 14 of 
CABG stimulation. Thus, the shift in SMCs phenotype 
in the media was likely an effect of the adaptation of 
the cells surviving the early apoptotic peak to the new 
mechanical conditions. This conclusion is in line with 
reported differences in biological responses of 
synthetic SMCs to mechanical strain compared to 
their contractile counterparts [36]. The different 
response of these cells in the CABG mechanical 
condition may be finally part of the TSP-1-mediated 
pathway, given the reported protective effects from 
apoptosis of TSP-1/CD47 interactions in SMCs [37]. 
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Figure 8. (A) Low and high magnifications (zones enclosed in the yellow areas) of transversal sections of porcine SV grafts before, and after 14 and 90 days in vivo arterialization. 
Yellow arrows indicate the intima basal lamina (BL). (B) Low and high magnifications (zones enclosed in the yellow areas) of section stained with anti TSP-1 antibody. Yellow 
arrows indicate TSP-1+ cells. (C) Quantification of intima thickening and of TSP-1+ cells. (D) Staining with antibodies directed against SM22α and CD44 of control (T0) and in vivo 
arterialized (day 14; day 90) SV in pigs. In the high magnifications on the bottom (correspondent to the zones enclosed in the yellow areas), orange arrows indicate cells 
expressing the two markers. * indicate P < 0.05 by one-way ANOVA with Newman-Keuls post-hoc test. Bar graphs represent mean and SE of observations. 
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Our immunofluorescence analyses of the SV wall 
revealed that in CABG condition, the vascular wall 
was repopulated by cells expressing the mesenchymal 
marker CD44 and early SMC marker SM22α. Due to 
marker overlapping between these strictly associated 
cell types, and the absence of methods to perform 
lineage-restricted cell tracking in the human tissue, it 
is at present not possible to conclude definitively 
whether these cells derive from direct activation of 
pre-existing CD44+/SM22α+ SMCs or of progenitors 
with pericyte characteristics associated to vasa 
vasorum[38]. CD44 is, in fact, the ligand for 
hyaluronan, and it is involved in cell-cell/cell-matrix 
interactions in SMCs, myofibroblasts and inflamma-
tory cells. This glycoprotein has been associated with 
SMCs differentiation [39], and high levels of CD44 
have been associated with cell migration, injury- 
induced remodeling and fibrosis [27, 40]. SM22α/ 
Transgelin is a F-Actin associated protein expressed in 
smooth muscle cells and fibroblasts, whose control 
has been recently associated to cell mechano- 
transduction [41]. Interestingly, in unstimulated 
samples SM22α+/CD44+ cells were found almost 
uniquely in the adventitia in the vasa vasorum region, 
from where they appeared to invade the media at the 
later time point, especially in CABG condition (Figure 
S3, Figure 5). This finding is suggestive of a two-step 
adventitial cells recruitment process consisting of, at 
first, activation in the adventitia and, thereafter, active 
migration/proliferation in the media. Although these 
results are in contrast with findings obtained by 
passive culturing of SV vein rings (where there is no 
intervention of mechanical forces, Figure S1-S2) [23], 
they confirm findings in real CABGs explanted post 
mortem, where no intima hyperplasia was observed 
up to one month after implantation [33] and previous 
results obtained in our laboratory showing a 
structural rearrangement of vasa vasorum in response 
to hypoxia or mechanical injuries [19, 25]. 
Furthermore, they are in line with studies showing 
the contribution of adventitial progenitors to vein 
graft failure in animal models of vein arterialization 
[24]. 
A matricellular pathway mediated by 
Thrombospondin-1 accounts for activation of 
resident myofibroblast-like cells in SVs 
exposed to coronary mechanics 
Cell sensitivity to mechanical cues is becoming 
more and more relevant for the progression of chronic 
fibrotic diseases as a fundamental part of damage 
repair process [42, 43]. Our in silico modelling of the 
cell strain in the two main layers of the SV wall 
predicted a particularly elevated level of mechanical 
stress for SMCs in the media (particularly those 
arranged in the circumferentially arranged bundles) 
(Figure 6). It was therefore crucial to expose these cells 
directly to cyclic mechanical stress in vitro and assess 
existence of signals secreted by these cells potentially 
involved in activation of adventitial resident cells. 
Given that in vivo mechanical stress sensed by these 
cells has a major uniaxial component [12], we 
performed a stimulation protocol along a unique 
direction with a 10% deformation level. Although this 
protocol led cells to experience a nominal deformation 
level lower than the maximal predicted by the model 
in the SV wall, we reasoned that mechanical forces in 
the real tissues is sensed by cells with a complex 
dynamics involving partial absorption by 
surrounding matrix due to its viscoelastic properties, 
while in the 2D condition cellular deformation occurs 
through direct transmission of elastic forces to 
cytoskeleton by the focal adhesion complexes [44]. 
The choice of a mass spectrometry approach to 
analyse the secretome of strained SMCs was made to 
not restrict our search for possible paracrine factors 
only on growth factors and chemokines that have 
been classically involved in progression of VGD, but 
also on the potential role of secreted proteins such as 
ECM components or matrix remodeling enzymes [29]. 
On the other hand, recent investigations by global 
proteomic profiling have disclosed new roles for 
ECM/matricellular vascular composition changes in 
early remodeling responses after injury [45]. Our 
secretomic analysis revealed TSP-1 as the factor more 
robustly released in the conditioned medium by 
SMCs subjected to mechanical stress. The role of 
TSP-1, and in a more general view, of members of the 
Thrombospondin family, have been so far connected 
to various effects on SMCs and vascular cells, such as 
focal adhesion kinase function, ERK1/2, p38 and 
CD44 regulation, migration, proliferation and arterial 
remodelling [46], but never specifically linked to 
VGD. This is important, especially in the view of 
recent evidences showing the susceptibility of TSP-1 
expression/function to mechanosensitive control in 
formation of aortic aneurysm [47] or in disturbed 
flow-dependent arterial stiffening [48]. Although the 
objective of the present study was not to establish 
links between the response to mechanical cues and 
TSP-1 secretion by SV-SMCs, or to unveil the identity 
of mechanotransduction-dependent machineries 
controlling TSP-1 gene expression at transcriptional 
level, it was remarkable to observe a sustained release 
of this factor specifically in the medial layer of 
CABG-stimulated human vessels (Figure 6, Figure 
S8), or in in vivo arterialized SV grafts (Figure 8). 
Together, these evidences support the hypothesis that 
release of TSP-1 in the vascular wall by SMCs is a 
damage response caused by SMCs mechanical stress 
Theranostics 2020, Vol. 10, Issue 6 
 
 
http://www.thno.org 
2610 
linked to the altered vessel flow dynamics, and 
potentially activating/recruiting adventitial cells with 
a myofibroblast phenotype. 
Inspired by the vision of a mechano-paracrine 
mechanism involving TSP-1 in SV remodeling 
process, we finally established a mechanism for 
activation of adventitial cells in SV graft pathophysio-
logic process. Even if these cells have been extensively 
characterized for their vascular regeneration potential 
[20], the expression of several markers in common 
with mesenchymal cells such as CD105, CD90 and 
CD44 (Figure S9) suggests a specific vascular patho-
physiologic role [38]. In our cell migration setting we 
observed a chemotactic effect of TSP-1 on SVPs. This 
effect was specific and involved CD47, one of the 
common TSP-1 receptor, expressed at high levels in 
these cells (Figure 7). Furthermore, compared to the 
treatment with the single factors, the combined 
treatment with TSP-1 and TGF-β increased SVPs 
maturation toward a SMC/myofibroblast phenotype, 
as shown by results of TAGLN1, TGFBR1 and Col1A 
genes expression, SM22 protein expression and 
proliferation (Figure 7, Figure S10-S11). Taken 
together, these results support a multiple role of TSP-1 
in activating myofibroblast-like progenitors migration 
from adventitial vasa vasorum and in modulating the 
latent TGF-β signaling, to promote maturation and 
proliferation of these cells in the media [49]. This 
hypothesis is in line with previous observations 
performed in mesenchymal progenitors [30] and 
SMCs [46], and establishes a new function of TSP-1 in 
early mechanical-dependent modification of matri-
cellular composition in human SV grafts. The 
potential of our mechano-dependent graft pathology 
model was finally tested in the SV into carotid 
interposition in pigs, a widely accepted, robust and 
reproducible large animal system to assess vein 
arterialization. Data obtained in this system (Figure 8) 
confirmed the overexpression of TSP-1 and in the 
vascular wall of transplanted SVs and a similar 
dynamics of SM22α/CD44+ in the adventitial region, 
and this correlated with neointima accumulation. 
In conclusion, our study unravels for the first 
time a molecular mechanism linking mechanical 
injury occurring in coronary SV grafts with 
programming of intima hyperplasia by a mechano- 
paracrine effect. While this evidence demonstrates the 
relevance of cell-based mechanosensing in fibrotic 
diseases of the cardiovascular system, it calls for more 
focused studies addressing the potential reduction of 
intima thickening, e.g. by treatments with peptides 
inhibiting the TSP-1 function to resolve the timely 
issue of venous CABGs occlusion [50]. 
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